Target intelligence / Profile preview

Novel transcript, antisense to zinc finger homeobox-3 (ENSG00000296181)

Target
ENSG00000296181
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

ENSG00000296181 encodes a novel, uncharacterized natural antisense transcript (NAT) oriented antisense to the zinc finger homeobox-3 (ZFHX3) gene. NATs are long non-coding RNAs (lncRNAs) transcribed from the opposite DNA strand of protein-coding or non-coding genes, often overlapping exons or regulatory regions of their partner gene[1]. For this specific transcript, there is no direct functional characterization or evidence supporting a role as a therapeutic target, nor association with drug interactions or specific disease. However, antisense lncRNAs are generally known to regulate their sense gene’s expression through mechanisms such as mRNA stabilization, interference with splicing, or chromatin modification, sometimes with tissue- and development-specific expression patterns[1]. ZFHX3, the sense gene counterpart, is a transcription factor crucial for nervous system development and circadian rhythm maintenance; by analogy, its antisense transcript may play a regulatory role in these pathways, but this remains speculative due to absence of supporting experimental data for ENSG00000296181.

Other names
Antisense RNA to ZFHX3NAT to ZFHX3ZFHX3-AS
02

Biological functions

Regulation of gene expression (putative)possible roles in mRNA stabilitytranscriptional interferencesplicing regulation (not experimentally established for this specific transcript, but inferred from general NAT/lncRNA biology)
03

Disease associations

Other (no direct established link to specific disease, but ZFHX3 and its regulatory networks are implicated in neurodevelopmental disorders and circadian rhythm regulation)

Beyond the preview

Go deeper on Novel transcript, antisense to zinc finger homeobox-3 (ENSG00000296181).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to zinc finger homeobox-3 (ENSG00000296181).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call